Precision radiation vs. standard care: a blind test for halting Cancer's advance
NCT ID NCT06918951
Summary
This study aims to see if a more precise, high-dose form of radiation (SABR) is better than standard palliative radiation at controlling cancer when it has spread to only a few new spots. About 194 adults with solid cancers that have progressed in up to five locations will be randomly assigned to receive one of the two radiation treatments. Neither the patients nor their doctors will know which treatment is given, to fairly compare how long the cancer stays controlled, quality of life, and side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLIGOPROGRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BC Cancer - Surrey
RECRUITINGSurrey, British Columbia, V3V 1Z2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.